Drawing for PRELUDE

USPTO serial 87330218

PRELUDE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BIBBINS, ODESSA
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with PRELUDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer Lee Taylor

JENNIFER LEE TAYLOR MORRISON & FOERSTER LLP425 MARKET STREETSAN FRANCISCO, CA 94105-2482UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medical diagnostic reagents and assays for testing of body fluids; prenatal test kits comprising chemical reagents and preparations for medical use in determining fetal chromosomal abnormalities; medical diagnostic reagents, preparations and diagnostic test kits consisting primarily of reagents for medical diagnostic purposes, namely, testing of fluids; chemical reagents for medical use in fetal nucleic acid analysis; diagnostic test kits comprised of chemical reagents and preparations for medical use in fetal nucleic acid analysis; diagnostic kits consisting primarily of reagents for nucleic acid analysis and for detecting genetic conditions, disorders and diseases for medical useABANDONEDJul 19, 2017
010Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of tissue-based diagnostic testing, cytology and cell-based testingABANDONEDJul 19, 2017
042Providing temporary use of non-downloadable computer software for customizing, selecting and ordering health and genetic analysis and diagnostic kits and assays and for accessing, viewing and storing health and genetic information via electronic, optical and wireless communication networksABANDONEDJul 19, 2017
044Genetic testing for medical purposesABANDONEDJul 19, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 15, 2019MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
Jan 15, 2019ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Jan 15, 2019OP.TOPPOSITION TERMINATED NO. 999999—
Jan 15, 2019OP.SOPPOSITION SUSTAINED NO. 999999—
May 21, 2018OP.IOPPOSITION INSTITUTED NO. 999999—
Jan 24, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 23, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 23, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 3, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 11, 2017ALIEASSIGNED TO LIE—
Nov 30, 2017AAUANOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED—
Nov 29, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 29, 2017IUAAUSE AMENDMENT ACCEPTED—
Nov 29, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Nov 29, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 29, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 29, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 8, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 7, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 7, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 4, 2017AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Nov 4, 2017IUAFUSE AMENDMENT FILED—
Nov 3, 2017EAAUTEAS AMENDMENT OF USE RECEIVED—
May 8, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 8, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 8, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2017DOCKASSIGNED TO EXAMINER—
Feb 14, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 13, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance